Cloud-based workspace collaboration software provider Genemod has raised $4.5 million in seed funding co-led by defy.vc and LDV Partners, with participation from Dolby Family Ventures and Vulcan/Cercano Ventures. The company’s cloud-based research platform is designed to digitize data capture and workflows to enable scientists to collaborate easily across an organization, accelerating life sciences R&D. Genemod’s software allows teams to eliminate busywork and other barriers, enabling them to focus on developments in biopharma. The company has expanded into the biopharma R&D space, working with startups and enterprise companies including AstraZeneca, Bristol-Myers, and Merck.
What You Should Know:
- Genemod, a cloud-based workspace collaboration software for biopharma R&D teams, today announced it raised $4.5 million in seed funding, co-led by defy.vc and LDV Partners, with participation from Dolby Family Ventures and Vulcan/Cercano Ventures.
- Genemod digitizes data capture and workflows, so scientists can collaborate easily across an organization to accelerate life sciences R&D.
Digitize Research Workflows in Minutes
Legacy R&D software and other traditional methods are decentralized, disorganized and inefficient, ultimately resulting in higher healthcare costs. Genemod is working to be the solution to this problem by building a dynamic cloud-based research platform designed for research teams to house their entire R&D lifecycle: from data acquisition and project documentation to inventory management and reporting. The intuitive interface allows users to easily visualize their data and track progress and updates – including what changes are made by whom.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
In the past year, Genemod has expanded into the biopharma R&D space working with teams from startups to enterprise companies including AstraZeneca, Bristol-Myers, Merck, and more. Working across siloed spreadsheets, updating data in real time and collaborating on projects in disparate geographical locations are just a few examples of how teams using Genemod are able to eliminate busywork and other barriers so they can focus on developments in biopharma.
Source: HitConsultant
